Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;79(3):395-404.
doi: 10.1111/bcp.12267.

Paediatric pharmacokinetics: key considerations

Hannah Katharine Batchelor, John Francis Marriott
Review

Paediatric pharmacokinetics: key considerations

Hannah Katharine Batchelor et al. Br J Clin Pharmacol. 2015 Mar.

Abstract

A number of anatomical and physiological factors determine the pharmacokinetic profile of a drug. Differences in physiology in paediatric populations compared with adults can influence the concentration of drug within the plasma or tissue. Healthcare professionals need to be aware of anatomical and physiological changes that affect pharmacokinetic profiles of drugs to understand consequences of dose adjustments in infants and children. Pharmacokinetic clinical trials in children are complicated owing to the limitations on blood sample volumes and perception of pain in children resulting from blood sampling. There are alternative sampling techniques that can minimize the invasive nature of such trials. Population based models can also limit the sampling required from each individual by increasing the overall sample size to generate robust pharmacokinetic data. This review details key considerations in the design and development of paediatric pharmacokinetic clinical trials.

PubMed Disclaimer

References

    1. EMA. 2001. ICH Topic E11. Clinical investigation of medicineal products in the paediatric population. CPMP/ICH/2711/99. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guidelin... (last accessed 11 October 2013)
    1. Bowles A, Keane J, Ernest T, Clapham D, Tuleu C. Specific aspects of gastro-intestinal transit in children for drug delivery design. Int J Pharm. 2010;395:37–43. - PubMed
    1. Kaye JL. Review of paediatric gastrointestinal physiology data relevant to oral drug delivery. Int J Clin Pharm. 2011;33:20–24. - PubMed
    1. Mooij MG, de Koning BA, Huijsman ML, de Wildt SN. Ontogeny of oral drug absorption processes in children. Expert Opin Drug Metab Toxicol. 2012;8:1293–1303. - PubMed
    1. Jöhr M. Unerwünschte Wachheit. Anaesthesist. 2006;55:1041–1050. - PubMed

Substances